This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murphy, K. M. Articles by Eshleman, J. R. Search for Related Content PubMed PubMed Citation Articles by Murphy, K. M. Articles by Eshleman, J. R.

JMD 2006, Vol. 8, No. 3
Copyright © 2006 American Society for Investigative Pathology & Association for Molecular Pathology

Comparison of the Microsatellite Instability Analysis System and the Bethesda Panel for the Determination of Microsatellite Instability in Colorectal Cancers

Kathleen M. Murphy^*, Shengle Zhang^*, Tanya Geiger^*, Michael J. Hafez^*, Jeff Bacher, Karin D. Berg^* and James R. Eshleman^*

From the Departments of Pathology * and Oncology, Johns Hopkins University School of Medicine; and Promega Corporation, Madison, Wisconsin

Microsatellite instability (MSI) analysis of colorectal cancers is clinically useful to identify patients with hereditary nonpolyposis colorectal cancer (HNPCC) caused by germline mutations of mismatch repair genes. MSI status may also predict cancer response/resistance to certain chemotherapies. We evaluated the MSI Analysis System (Promega Corp.; five mononucleotide and two pentanucleotide repeats) and compared the results to the Bethesda panel, which interrogates five microsatellite loci recommended by the 1997 National Cancer Institute-sponsored MSI workshop (three dinucleotide and two mononucleotide repeats). Thirty-four colorectal cancers were analyzed by both assays. The overall concordance between the two assays was 85% (29 of 34). There was complete concordance between the two assays for all of the MSI-high (11 of 11) and microsatellite stable (MSS; 18 of 18) cases. In the 11 MSI-high cases, all 5 of the mononucleotide loci in the MSI Analysis System demonstrated shifted alleles (100% sensitivity), and each shift resulted in products that were smaller in size than the germline alleles. All (5 of 5) of the cases interpreted as MSI-low by the Bethesda assay were interpreted as MSS by the MSI Analysis System. Our results suggest that the MSI Analysis System is generally superior and may help resolve cases of MSI-low into either MSI-high or MSS.

This article has been cited by other articles:

				M. Bujalkova, K. Zavodna, T. Krivulcik, D. Ilencikova, B. Wolf, M. Kovac, J. Karner-Hanusch, K. Heinimann, G. Marra, J. Jiricny, et al. Multiplex SNaPshot Genotyping for Detecting Loss of Heterozygosity in the Mismatch-Repair Genes MLH1 and MSH2 in Microsatellite-Unstable Tumors Clin. Chem., November 1, 2008; 54(11): 1844 - 1854. [Abstract] [Full Text] [PDF]

				L. Zhang Immunohistochemistry versus Microsatellite Instability Testing for Screening Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome: Part II. The Utility of Microsatellite Instability Testing J. Mol. Diagn., July 1, 2008; 10(4): 301 - 307. [Abstract] [Full Text] [PDF]

				V. Deschoolmeester, M. Baay, W. Wuyts, E. Van Marck, N. Van Damme, P. Vermeulen, K. Lukaszuk, F. Lardon, and J. B. Vermorken Detection of Microsatellite Instability in Colorectal Cancer Using an Alternative Multiplex Assay of Quasi-Monomorphic Mononucleotide Markers J. Mol. Diagn., March 1, 2008; 10(2): 154 - 159. [Abstract] [Full Text] [PDF]

				S. Ogino and A. Goel Molecular Classification and Correlates in Colorectal Cancer J. Mol. Diagn., January 1, 2008; 10(1): 13 - 27. [Abstract] [Full Text] [PDF]